Clinical Trial Update: The STandard Versus ImAging SuBstrate Aided Ablation in Severe Left VEntricular Dysfunction VT. [NA]

View source ↗

Summary

A clinical trial evaluating ablation strategies for ventricular tachycardia in patients with severe left ventricular dysfunction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction
• Ventricular Tachycardia

Snippet

Sponsor: University of Pennsylvania | Conditions: Cardiovascular Diseases | NA | Status: WITHDRAWN